NRX PHARMACEUTICALS INC *W EXP 05/24/202 is a security (CUSIP 629444118) tracked across SEC portfolio filings. 3 institutional managers reported $347 on Form 13F as of 2026-03-31.
| Manager | Location | Value | Shares |
|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | CHICAGO, IL | $347 | 23,593 |
| UBS Group AG | Zurich, V8 | — | 13 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |